HK:2487 Stock Latest News
Company AnnouncementsCutia Therapeutics Expands Global Collaboration with Rejuven for Obesity-Targeted Drug CU-204014w ago2487
Company AnnouncementsCutia Therapeutics Unveils Targeted Share Buyback to Signal Confidence1M ago2487
Company AnnouncementsCutia Therapeutics Reshapes Board With CFO Exit and R&D Chief Promotion1M ago2487
Company AnnouncementsCutia Wins Macao Approval for Topical Finasteride, Advancing Scalp Care Strategy1M ago2487
Company AnnouncementsCutia Therapeutics’ Botulinum Toxin CU-20101 BLA Accepted by China’s NMPA2M ago2487
Company AnnouncementsCutia Therapeutics Accelerates Commercial Push in China’s Dermatology Market2M ago2487Company AnnouncementsCutia Therapeutics Sets Board Meeting to Approve Interim Results and Consider Dividend3M ago2487
Company AnnouncementsCutia Wins NMPA Nod for Topical Anesthesia Cream, Expanding China Dermatology Portfolio6M ago2487
Company AnnouncementsCutia Therapeutics Changes Cayman Share Registrar Name Without Moving Registered Office6M ago2487
Company AnnouncementsCutia Therapeutics Sets 2026 AGM to Vote on Board, Auditor and Share Mandates6M ago2487
Company AnnouncementsCutia Therapeutics’ Botox Rival Meets Phase III Goals in China7M ago2487
Company AnnouncementsCutia Therapeutics Boosts Revenue and Margins as Key Dermatology Products Launch in 20257M ago2487Company AnnouncementsCutia Therapeutics Wins China Trial Nod for New Topical Hair-Loss Drug8M ago2487
Company AnnouncementsCutia Therapeutics Sets March 2026 Board Meeting to Approve 2025 Annual Results8M ago2487
Company AnnouncementsCutia Therapeutics’ Botulinum Toxin CU-20101 Meets Phase III Goals in China10M ago2487
Company AnnouncementsCutia Therapeutics Updates Board and Committee Structure10M ago2487
Company AnnouncementsCutia Therapeutics’ Topical Finasteride Spray Gains Regulatory Acceptance1y ago2487
Company AnnouncementsCutia Therapeutics’ Acne Treatment Shows Promising Early Results1y ago2487



